p-dsip concentration blood DSIP – Research Peptide a Blood concentration i.v. and

Wednesday, 28 January 2026 Expansion of SVN-015 into depression following positive preclinical data Solvonis Therapeutics plc (Solvonis or the Company) Expansion of SVN-015 into depression following positive preclinical data Demonstrates antidepressant-like activity benchmarked against fluoxetine (Prozac), supporting potential in patients with inadequate SSRI response Solvonis Therapeutics plc (LSE: SVNS) , an emerging biopharmaceutical company developing novel medicines for high-burden central nervous system (CNS) disorders, announces the expansion of its investigational compound SVN-015 into the treatment of depression, supported by preclinical data demonstrating antidepressant-like activity benchmarked against fluoxetine

Ro advises anyone interested in peptide medication to talk to a healthcare provider about a prescription, and Forhers positions its own telehealth service as the route to FDA-approved GLP-1 options

Pretty simple, eh

Because GHK is a naturally occurring peptide already present in human plasma, serum, saliva, and urine, the body recognizes it as endogenous rather than foreign